Johnson & Johnson
This company’s brands:
Johnson & Johnson is a U.S.-based healthcare conglomerate founded in 1886, now operating primarily in pharmaceuticals and medical devices after spinning off its consumer brands in 2023. With a global footprint and annual revenues exceeding $90 billion, it remains one of the most influential health corporations in the world. J&J has faced repeated scandals and litigation, including asbestos-contaminated talc, billions in opioid settlements, and fines for unlawful drug marketing.
Beyond litigation, it funds and operates research partnerships in Israel, including the FutuRx biopharma incubator and acquisitions like Omrix, embedding its capital into Israel’s innovation economy. Animal testing also remains central to its drug and device development.